Physician profile
Ryan Payne
NPI 1235685512
$1,396.48
in general payments reported to CMS, 2019-2025
11 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $69.04 · 2023: $439 · 2024: $522 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.63 |
| Education | $110.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $476.85 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $367.93 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $129.05 | 2022-2025 | Nucala |
| Hikma Pharmaceuticals USA | $89.39 | 2023-2025 | Ryaltris |
| Phathom Pharmaceuticals, INC. | $85.25 | 2025 | Voquezna |
| Medtronic, INC. | $83.94 | 2024 | Nuvent, Propel |
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Optinose US, INC. | $49.35 | 2025 | |
| Phadia US INC. | $24.21 | 2024 | Immunocap |
| Inspire Medical Systems, INC. | $20.03 | 2025 | Inspire |
| Photonicare INC | $17.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.